These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33238073)

  • 1. Histiocytic and dendritic cell neoplasms: Reappraisal of a Japanese series based on t(14;18) and neoplastic PD-L1 expression.
    Okada K; Takahara T; Suzuki Y; Kohno K; Sakakibara A; Satou A; Takahashi E; Nakamura S
    Pathol Int; 2021 Jan; 71(1):24-32. PubMed ID: 33238073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of clonal IG and T-cell receptor gene rearrangements in histiocytic and dendritic cell neoplasms.
    Huang W; Qiu T; Zeng L; Zheng B; Ying J; Feng X
    Oncotarget; 2016 Nov; 7(48):78355-78362. PubMed ID: 27823979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone.
    Feldman AL; Arber DA; Pittaluga S; Martinez A; Burke JS; Raffeld M; Camos M; Warnke R; Jaffe ES
    Blood; 2008 Jun; 111(12):5433-9. PubMed ID: 18272816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases.
    Shao H; Xi L; Raffeld M; Feldman AL; Ketterling RP; Knudson R; Rodriguez-Canales J; Hanson J; Pittaluga S; Jaffe ES
    Mod Pathol; 2011 Nov; 24(11):1421-32. PubMed ID: 21666687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.
    Gatalica Z; Bilalovic N; Palazzo JP; Bender RP; Swensen J; Millis SZ; Vranic S; Von Hoff D; Arceci RJ
    Oncotarget; 2015 Aug; 6(23):19819-25. PubMed ID: 26110571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of clonal immunoglobulin receptor gene rearrangements in sporadic histiocytic/dendritic cell sarcomas.
    Chen W; Lau SK; Fong D; Wang J; Wang E; Arber DA; Weiss LM; Huang Q
    Am J Surg Pathol; 2009 Jun; 33(6):863-73. PubMed ID: 19145200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follicular dendritic cell sarcoma: clinicopathologic study of 15 cases with emphasis on novel expression of MDM2, somatostatin receptor 2A, and PD-L1.
    Agaimy A; Michal M; Hadravsky L; Michal M
    Ann Diagn Pathol; 2016 Aug; 23():21-8. PubMed ID: 27402219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Descriptive Analysis of Histiocytic and Dendritic Cell Neoplasms: A Single-Institution Experience.
    Kim HM; Yang WI; Lyu CJ; Hahn SM; Yoon SO
    Yonsei Med J; 2020 Sep; 61(9):774-779. PubMed ID: 32882761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonally related follicular lymphomas and Langerhans cell neoplasms: expanding the spectrum of transdifferentiation.
    West DS; Dogan A; Quint PS; Tricker-Klar ML; Porcher JC; Ketterling RP; Law ME; McPhail ED; Viswanatha DS; Kurtin PJ; Dao LN; Ritzer RD; Nowakowski GS; Feldman AL
    Am J Surg Pathol; 2013 Jul; 37(7):978-86. PubMed ID: 23759932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phosphatidylserine receptors, T cell immunoglobulin mucin proteins 3 and 4, are markers of histiocytic sarcoma and other histiocytic and dendritic cell neoplasms.
    Dorfman DM; Hornick JL; Shahsafaei A; Freeman GJ
    Hum Pathol; 2010 Oct; 41(10):1486-94. PubMed ID: 20656318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
    Massoth LR; Hung YP; Ferry JA; Hasserjian RP; Nardi V; Nielsen GP; Sadigh S; Venkataraman V; Selig M; Friedmann AM; Samore W; Killian JK; Milante R; Giessinger J; Foley-Peres K; Marcus C; Severson E; Duncan D; Sivakumar S; Ross JS; Desphande V; Ramkissoon SH; Vergilio JA; Louissaint A; Zukerberg LR; Williams EA
    Oncologist; 2021 Jul; 26(7):e1263-e1272. PubMed ID: 33904632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive Histogenesis and Immunological Microenvironment Based on Transcriptional Profiles of Follicular Dendritic Cell Sarcomas.
    Laginestra MA; Tripodo C; Agostinelli C; Motta G; Hartmann S; Döring C; Rossi M; Melle F; Sapienza MR; Tabanelli V; Pileri A; Fuligni F; Gazzola A; Mannu C; Sagramoso CA; Lonardi S; Lorenzi L; Bacci F; Sabattini E; Borges A; Simonitsch-Klupp I; Cabecadas J; Campo E; Rosai J; Hansmann ML; Facchetti F; Pileri SA
    Mol Cancer Res; 2017 May; 15(5):541-552. PubMed ID: 28130401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors.
    Yu H; Gibson JA; Pinkus GS; Hornick JL
    Am J Clin Pathol; 2007 Nov; 128(5):776-82. PubMed ID: 17951199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine needle aspiration cytology of histiocytic sarcoma with dendritic cell differentiation: a case of transdifferentiation from low-grade follicular lymphoma.
    Mehrotra S; Pan Z
    Diagn Cytopathol; 2015 Aug; 43(8):659-63. PubMed ID: 25993973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.
    Pileri SA; Grogan TM; Harris NL; Banks P; Campo E; Chan JK; Favera RD; Delsol G; De Wolf-Peeters C; Falini B; Gascoyne RD; Gaulard P; Gatter KC; Isaacson PG; Jaffe ES; Kluin P; Knowles DM; Mason DY; Mori S; Müller-Hermelink HK; Piris MA; Ralfkiaer E; Stein H; Su IJ; Warnke RA; Weiss LM
    Histopathology; 2002 Jul; 41(1):1-29. PubMed ID: 12121233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential development of histiocytic sarcoma and diffuse large b-cell lymphoma in a patient with a remote history of follicular lymphoma with genotypic evidence of a clonal relationship: a divergent (bilineal) neoplastic transformation of an indolent B-cell lymphoma in a single individual.
    Wang E; Papalas J; Hutchinson CB; Kulbacki E; Huang Q; Sebastian S; Rehder C; Silbermins D; Moore J; Datto M
    Am J Surg Pathol; 2011 Mar; 35(3):457-63. PubMed ID: 21317718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KRAS mutation in secondary malignant histiocytosis arising from low grade follicular lymphoma.
    Choi SM; Andea AA; Wang M; Behdad A; Shao L; Zhang Y; Lu X; Dittmann D; Castro J; Chen YH; Gao J
    Diagn Pathol; 2018 Oct; 13(1):78. PubMed ID: 30322385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Programmed Cell Death 1 Ligands (PD-L1 and PD-L2) in Histiocytic and Dendritic Cell Disorders.
    Xu J; Sun HH; Fletcher CD; Hornick JL; Morgan EA; Freeman GJ; Hodi FS; Pinkus GS; Rodig SJ
    Am J Surg Pathol; 2016 Apr; 40(4):443-53. PubMed ID: 26752545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular lymphoma.
    Fernandez-Pol S; Bangs CD; Cherry A; Arber DA; Gratzinger D
    Hum Pathol; 2016 Sep; 55():39-43. PubMed ID: 27134111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From the archives of MD Anderson Cancer Center: A case of concurrent follicular lymphoma and Langerhans cell sarcoma with a review of the literature.
    Tashakori M; Thakral B; Tang G; Khoury JD; Medeiros LJ
    Ann Diagn Pathol; 2021 Jun; 52():151720. PubMed ID: 33676171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.